Kaletra pharmacokinetics have not been studied in patients with renal insufficiency; however, since the renal clearance of lopinavir is negligible, a decrease in total body clearance is not expected in patients with renal insufficiency.
Sisältö: propyleeniglykolia, makrogoliglyserolirisiinioletaatti 35: a, nestemäistä sorbitolianhydridia (sorbitolin, sorbitolianhydridien ja mannitolin seos), glyserolia ja paraoranssia (E110).